FDG-PET for preoperative differential diagnosis between benign and malignant soft tissue masses
- 24 January 2003
- journal article
- research article
- Published by Springer Nature in Skeletal Radiology
- Vol. 32 (3) , 133-138
- https://doi.org/10.1007/s00256-002-0586-9
Abstract
To evaluate the standardized uptake value (SUV) of [18F]2-deoxy-2-fluoro-d-glucose at positron emission tomography (FDG-PET) for preoperative differential diagnosis between benign and malignant soft tissue masses.Keywords
This publication has 27 references indexed in Scilit:
- FDG PET of Primary Benign and Malignant Bone Tumors: Standardized Uptake Value in 52 LesionsRadiology, 2001
- PET imaging in oncologySeminars in Nuclear Medicine, 2000
- Glucose metabolic analysis of musculoskeletal tumours using 18fluorine-FDG PET as an aid to preoperative planningThe Journal of Bone and Joint Surgery. British volume, 2000
- Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomographyBritish Journal of Surgery, 1999
- A PET study of 18 FDG uptake in soft tissue massesEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?European Journal of Nuclear Medicine and Molecular Imaging, 1997
- PET in oncology: Will it replace the other modalities?Seminars in Nuclear Medicine, 1997
- Glucose transporters in rat peripheral nerve: Paranodal expression of GLUT1 and GLUT3Metabolism, 1996
- Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Magnetic resonance imaging of soft tissue masses: An evaluation of fifty-three histologically proven tumorsMagnetic Resonance Imaging, 1988